17-7224711-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_000018.4(ACADVL):āc.1748C>Gā(p.Ser583Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00000554 in 1,444,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000018.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1444792Hom.: 0 Cov.: 36 AF XY: 0.00000557 AC XY: 4AN XY: 717598
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Very long chain acyl-CoA dehydrogenase deficiency Pathogenic:4Uncertain:1
- -
The NM_000018.3:c.1748C>G (NP_000009.1:p.Ser583Trp) [GRCH38: NC_000017.11:g.7224711C>G] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID: 9599005 . This variant meets the following evidence codes reported in the ACMG guidelines: PS1, PS3 -
Variant summary: ACADVL c.1748C>G (p.Ser583Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 224028 control chromosomes (gnomAD). c.1748C>G has been reported in the literature in at least one individual affected with Very Long Chain Acyl-CoA Dehydrogenase Deficiency and in individuals identified through newborn screening (Souri_1998, Olsen_2010, Miller_2015, Hesse_2018). Experimental evidence demonstrated the variant affects protein function (Souri_1998). Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic and two ClinVar submitters (evaluation after 2014) cite it as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
This sequence change replaces serine, which is neutral and polar, with tryptophan, which is neutral and slightly polar, at codon 583 of the ACADVL protein (p.Ser583Trp). This variant is present in population databases (no rsID available, gnomAD 0.007%). This missense change has been observed in individual(s) with very long-chain acyl-CoA dehydrogenase deficiency (PMID: 9599005, 20480395, 26385305). ClinVar contains an entry for this variant (Variation ID: 426482). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ACADVL protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects ACADVL function (PMID: 9599005). This variant disrupts the p.Ser583 amino acid residue in ACADVL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15210884, 16464760, 23774949). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
ACADVL-related disorder Pathogenic:1
The ACADVL c.1748C>G variant is predicted to result in the amino acid substitution p.Ser583Trp. This variant was reported in individuals with very long chain acyl-CoA dehydrogenase deficiency, though a second variant was not identified in any of these reports (Hesse et al. 2018. PubMed ID: 30194637; Supplementary Table S2, Miller et al. 2015. PubMed ID: 26385305; Souri et al. 1998. PubMed ID: 9599005). In vitro models demonstrate that this variant disrupts ACADVL protein association with the inner mitochondrial membrane and dimer assembly (Souri et al. 1998. PubMed ID: 9599005). Residual ACADVL enzyme activity was reported to be only 28% of wild type in an individual heterozygous for the c.1748C>G change, further suggesting a loss of function mechanism (Hesse et al. 2018. PubMed ID: 30194637). This variant is reported in 0.0065% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-7128030-C-G). This variant is interpreted as pathogenic. -
not provided Pathogenic:1
Reported in individuals with positive newborn screens for very long chain acyl-CoA dehydrogenase deficiency, although it is unknown if these individuals harbored another ACADVL gene variant (PMID: 26385305); Functional analyses found that p.(S583W) is associated with impaired dimerization and 19% residual enzyme activity compared to wild type (PMID: 9599005); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8554073, 30194637, 26385305, 9599005) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at